Item 2.02. Results of Operations and Financial Condition.



On January 10, 2022, Isoplexis Corporation (the "Company") issued a press
release reporting its preliminary unaudited financial revenue for the year ended
December 31, 2021. A copy of the press release is furnished herewith as Exhibit
99.1.

The information furnished with this Item 2.02, including Exhibit 99.1, shall not
be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference into any other
filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as expressly set forth by specific reference in such a filing.

--------------------------------------------------------------------------------

Item 7.01. Regulation FD Disclosure.



Beginning on January 10, 2022, ancillary to the 40th Annual J.P. Morgan
Healthcare Conference, the Company will be meeting with certain analysts and
investors and will be providing a presentation ("Investor Presentation") to such
analysts and investors, discussing, among other topics, an overview of the
Company's business and growth strategy. A copy of the Investor Presentation,
which is available at www.isoplexis.com, is being furnished as Exhibit 99.2 to
this Form 8-K and is incorporated herein by reference.

The information furnished with this Item 7.01, including Exhibit 99.2, shall not
be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated
by reference into any other filing under the Securities Act of 1933, as amended,
or the Exchange Act, except as expressly set forth by specific reference in such
a filing.

--------------------------------------------------------------------------------


ITEM 9.01. Financial Statements and Exhibits
(d) Exhibits
Exhibit No.                                                Description

  99.1                    Press Release of IsoPlexis Corporation    ,     dated January     9    , 2022

  99.2                    Isoplexis Investor Presentation, dated January     10    , 2022

104                     Cover Page Interactive Data File (embedded within

the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses